4,475 Shares in Aflac Incorporated $AFL Bought by HORAN Wealth LLC

HORAN Wealth LLC acquired a new position in Aflac Incorporated (NYSE:AFL) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 4,475 shares of the financial services provider’s stock, valued at approximately $472,000.

Other institutional investors also recently modified their holdings of the company. Nuveen LLC acquired a new position in Aflac in the first quarter valued at $140,746,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Aflac in the second quarter valued at $60,954,000. Citigroup Inc. lifted its holdings in Aflac by 133.2% in the first quarter. Citigroup Inc. now owns 758,424 shares of the financial services provider’s stock valued at $84,329,000 after buying an additional 433,134 shares during the period. Guinness Asset Management LTD lifted its holdings in Aflac by 19.4% in the second quarter. Guinness Asset Management LTD now owns 2,372,484 shares of the financial services provider’s stock valued at $250,187,000 after buying an additional 385,546 shares during the period. Finally, Goldman Sachs Group Inc. lifted its holdings in Aflac by 10.8% in the first quarter. Goldman Sachs Group Inc. now owns 3,575,054 shares of the financial services provider’s stock valued at $397,510,000 after buying an additional 349,787 shares during the period. Institutional investors own 67.44% of the company’s stock.

Aflac Price Performance

Shares of NYSE AFL opened at $111.23 on Thursday. The firm’s 50-day moving average price is $108.69 and its 200-day moving average price is $105.63. Aflac Incorporated has a 1-year low of $96.95 and a 1-year high of $115.43. The firm has a market capitalization of $59.49 billion, a P/E ratio of 25.22, a P/E/G ratio of 2.93 and a beta of 0.83. The company has a current ratio of 0.11, a quick ratio of 0.11 and a debt-to-equity ratio of 0.33.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Monday, February 27th. The financial services provider reported $1.07 earnings per share for the quarter. Aflac had a net margin of 15.32% and a return on equity of 15.08%. The firm had revenue of $5.91 billion for the quarter. Equities research analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac announced that its board has authorized a share buyback program on Tuesday, August 12th that allows the company to repurchase 100,000,000 outstanding shares. This repurchase authorization allows the financial services provider to buy shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Aflac Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 1st. Investors of record on Wednesday, November 19th will be issued a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Wednesday, November 19th. Aflac’s dividend payout ratio is currently 30.29%.

Insider Buying and Selling at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $102.57, for a total value of $102,570.00. Following the sale, the director owned 25,105 shares in the company, valued at $2,575,019.85. This represents a 3.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.90% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on AFL shares. Wells Fargo & Company boosted their target price on shares of Aflac from $105.00 to $107.00 and gave the company an “equal weight” rating in a report on Monday, August 11th. Barclays restated an “underweight” rating and issued a $104.00 target price (up previously from $102.00) on shares of Aflac in a report on Wednesday. Keefe, Bruyette & Woods boosted their target price on shares of Aflac from $108.00 to $110.00 and gave the company a “market perform” rating in a report on Thursday, October 9th. Weiss Ratings restated a “buy (b-)” rating on shares of Aflac in a report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Aflac from $100.00 to $101.00 and gave the company a “neutral” rating in a report on Wednesday. Three equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Aflac presently has a consensus rating of “Hold” and a consensus price target of $110.20.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.